Thursday, February 2, 2023
HomeTop StoriesMonkeypox antiviral drug put to the test in trial

Monkeypox antiviral drug put to the test in trial


Tecovirimat prevents the virus from leaving infected cells, stopping its spread within the body. It was licensed earlier this year for monkeypox, based on promising results from initial studies in animals and evidence of safety in healthy human volunteers.



Source link

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments